Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis.
Hiroki IrieRei SuzukiTadayuki TakagiMitsuru SugimotoNaoki KonnoYuki SatoTakuto HikichiJun NakamuraMinami HashimotoHiromasa OhiraPublished in: Cancer chemotherapy and pharmacology (2019)
ILD was observed in 18.9% of PDAC patients treated with GnP therapy. With appropriate management, no prognostic influence was observed.